Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Dina M. Kweekel"'
Publikováno v:
Therapeutic Drug Monitoring.
Autor:
Dina M. Kweekel, Johan W. de Fijter, Tom C. Zwart, Paul J M van der Boog, Henk-Jan Guchelaar, Dirk Jan A.R. Moes, Jesse J. Swen, Sumit R.M. Gokoel
Publikováno v:
British Journal of Clinical Pharmacology. 84:2889-2902
Aims Tacrolimus and mycophenolic acid dosing after renal transplantation is individualized through therapeutic drug monitoring (TDM). Home-based dried blood spot (DBS) sampling has the potential to replace conventional TDM sampling at the clinic. A l
Autor:
Dina M. Kweekel, Floor J E Lubberman, Carli Michèle Wilmer, Hans Gelderblom, Winette T. A. van der Graaf, David M. Burger, Nielka P. van Erp, Ingrid M.E. Desar, Angela Colbers
Publikováno v:
British Journal of Clinical Pharmacology, 83, 10, pp. 2312-2314
British Journal of Clinical Pharmacology, 83(10), 2312-2314
British Journal of Clinical Pharmacology, 83, 2312-2314
British Journal of Clinical Pharmacology, 83(10), 2312-2314
British Journal of Clinical Pharmacology, 83, 2312-2314
Contains fulltext : 176994.pdf (Publisher’s version ) (Closed access)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82dc7527b63ee4fce4755dfe9f50ac1c
https://doi.org/10.1111/bcp.13333
https://doi.org/10.1111/bcp.13333
Autor:
Henk-Jan Guchelaar, Johan W. R. Nortier, Ninja Antonini, Dina M. Kweekel, Cornelis J. A. Punt, Hans Gelderblom, Tahar van der Straaten
Publikováno v:
European journal of cancer (Oxford, England, 45(4), 572-578. Elsevier Limited
European Journal of Cancer, 45, 4, pp. 572-8
European Journal of Cancer, 45, 572-8
European Journal of Cancer, 45, 4, pp. 572-8
European Journal of Cancer, 45, 572-8
Item does not contain fulltext PURPOSE: Oxaliplatin is detoxified by conjugation to glutathione via the enzyme Glutathione-S-transferase pi (GSTP1). The aim of this study is to investigate the association of GSTP1 Ile105Val genetic polymorphism with
Autor:
Dina M. Kweekel, Saskia Le Cessie, Henk-Jan Guchelaar, Pieter Vermeij, Pieter J. Van den Broek, Irene M. Twiss
Publikováno v:
American Journal of Health-System Pharmacy. 61:1702-1706
Autor:
Henk-Jan Guchelaar, Kees L. M. C. Franken, Tahar van der Straaten, Xiaobo Lu, Lieke H. van Huis-Tanja, Cornelis J. A. Punt, Hans Gelderblom, Dina M. Kweekel, Miriam Koopman, Ninja Antonini
Publikováno v:
Mutation research, 759, 37-44. Elsevier
Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis, 759, 37-44
Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis, 759, 37-44
Aims ERCC1 is involved in the repair of oxaliplatin-induced DNA damage. Studies for the association of the C118T SNP with clinical response to treatment with platinum drugs have rendered inconsistent results. We investigated the ERCC1 C118T SNP with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0780c805a795f16862acc140f323fbbd
https://pure.amc.nl/en/publications/excision-repair-crosscomplementation-group-1-ercc1-c118t-snp-does-not-affect-cellular-response-to-oxaliplatin(6ce32567-300e-433a-8252-174dc4f3386b).html
https://pure.amc.nl/en/publications/excision-repair-crosscomplementation-group-1-ercc1-c118t-snp-does-not-affect-cellular-response-to-oxaliplatin(6ce32567-300e-433a-8252-174dc4f3386b).html